Sylon Bio Pharma Private Limited, a active private limited company, was established on 22 November 2006 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the trade sector, it holds CIN: U24232TG2006PTC051758. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.34 M.
It upholds a compliant status. Its leadership includes Sripada Maha Lakshimi (Director), Sripada Shyam Sunder (Director). Past directors included Pabba Neelakantam. It holds ₹5.52 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 2-5-114/24, Sai Ram Hills Colony Road No. 3, Nagole, Hyderabad, Telangana, 500068.
U24232TG2006PTC051758
051758
22 November 2006
₹2.50 M
₹2.34 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sylon Bio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sripada Maha Lakshimi | Director | 25 Feb 2021 | Current |
| Sripada Shyam Sunder | Director | 26 Nov 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 24 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sylon Bio Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 171.86% increase. The company also saw a substantial improvement in profitability, with a 419.84% increase in profit. The company's net worth moved up by a moderate rise of 9.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sylon Bio Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹55,215,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2025 | Yes Bank Limited | ₹6.00 M | Open |
| 16 Nov 2019 | Others | ₹3.92 Cr | Open |
| 15 Jun 2007 | Ing Vysya Bank Limited | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sylon Bio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sylon Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sylon Bio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Yes Bank Limited amounted to Rs. 6.00 M with Charge ID 101119852 was registered on 29 Apr 2025. was documented.
Sylon Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Sylon Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Sripada Maha Lakshimi was appointed as a Director was appointed as a Director on 25 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
Progress on A charge with Others amounted to Rs. 39.22 M with Charge ID 100302353 was registered on 16 Nov 2019. was documented.
The activity A charge with Ing Vysya Bank Limited of Rs. 10.00 M registered on 15 Jun 2007 with Charge ID 10061564 was modified on 01 Dec 2012. was completed.
The CIN of Sylon Bio Pharma Private Limited is U24232TG2006PTC051758.
Sylon Bio Pharma Private Limited is headquartered at H. No. 2-5-114/24, Sai Ram Hills Colony Road No. 3, Nagole, Hyderabad, Telangana, 500068.
Sylon Bio Pharma Private Limited was incorporated on 22 November 2006.
The current directors of Sylon Bio Pharma Private Limited are
The primary industry of Sylon Bio Pharma Private Limited is Trade.
Sylon Bio Pharma Private Limited is unlisted.
The authorized capital of Sylon Bio Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.34 M.
The compliance status of Sylon Bio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX